We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

bioMérieux and Hitachi Partnership to Focus on Microbiology and Molecular Diagnostics

By HospiMedica staff writers
Posted on 25 Mar 2008
bioMerieux (Marcy l'Etoile, France), an in-vitro diagnostics company, and Hitachi High-Technologies Corp.(Tokyo, Japan) have entered into a long-term strategic partnership. They plan to identify and develop new microbiology and molecular diagnostic systems.

New instruments developed under the partnership will be manufactured by Hitachi High-Technologies and distributed through bioMérieux's worldwide commercial network. bioMérieux is present in more than 150 countries through 38 subsidiaries and a large network of distributors. Teams from bioMérieux and Hitachi High-Technologies are working together toward development milestones on a new system.

"bioMérieux's vision, and a key objective of our 2012 strategy, is to bring full automation to microbiology laboratories around the world. This partnership enables bioMérieux to work with extremely talented engineers from Hitachi High-Technologies Corporation to better serve our customers,” said Stéphane Bancel, CEO of bioMérieux. "We will also introduce innovative systems to molecular diagnostics, leveraging bioMérieux's expertise in biology and Hitachi High-Technologies Corporation's remarkable engineering capabilities,” he added.


Related Links:
bioMerieux
Hitachi High-Technologies Corporation

Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Automated Blood Typing System
IH-500 NEXT
New
Newborn Screening Test
NeoMass AAAC 3.0
New
Urine Strips
11 Parameter Urine Strips

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests